Literature DB >> 19464853

A double-blind trial of adjunctive azithromycin in individuals with schizophrenia who are seropositive for Toxoplasma gondii.

Faith B Dickerson, Cassie R Stallings, John J Boronow, Andrea E Origoni, Robert H Yolken.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19464853     DOI： 10.1016/j.schres.2009.05.005

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


× No keyword cloud information.
  8 in total

Review 1.  The environment and susceptibility to schizophrenia.

Authors:  Alan S Brown
Journal:  Prog Neurobiol       Date:  2010-10-16       Impact factor: 11.685

2.  A classification of sociomedical health indicators: perspectives for health administrators and health planners.

Authors:  A E Siegmann
Journal:  Int J Health Serv       Date:  1976       Impact factor: 1.663

Review 3.  Neuropsychiatric Effects of Antimicrobial Agents.

Authors:  Nicholas Zareifopoulos; George Panayiotakopoulos
Journal:  Clin Drug Investig       Date:  2017-05       Impact factor: 2.859

Review 4.  Toxoplasma gondii and schizophrenia: a review of published RCTs.

Authors:  Sam D Chorlton
Journal:  Parasitol Res       Date:  2017-05-15       Impact factor: 2.289

5.  The Effect of Fluphenazine and Thioridazine on Toxoplasma gondii In Vivo.

Authors:  Mehrzad Saraei; Yosef Ghaderi; Tahereh Mosavi; Mojtaba Shahnazi; Marjan Nassiri-Asl; Hassan Jahanihashemi
Journal:  Iran J Parasitol       Date:  2016 Apr-Jun       Impact factor: 1.012

6.  Toxoplasmosis and Schizophrenia: A Systematic Review and Meta-Analysis of Prevalence and Associations and Future Directions.

Authors:  Despina G Contopoulos-Ioannidis; Maria Gianniki; Angeline Ai-Nhi Truong; Jose G Montoya
Journal:  Psychiatr Res Clin Pract       Date:  2022-04-22

Review 7.  Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials.

Authors:  Stefano Marini; Domenico De Berardis; Federica Vellante; Rita Santacroce; Laura Orsolini; Alessandro Valchera; Gabriella Girinelli; Alessandro Carano; Michele Fornaro; Francesco Gambi; Giovanni Martinotti; Massimo Di Giannantonio
Journal:  Mediators Inflamm       Date:  2016-07-25       Impact factor: 4.711

Review 8.  Autoimmune phenotypes in schizophrenia reveal novel treatment targets.

Authors:  Emily G Severance; Faith B Dickerson; Robert H Yolken
Journal:  Pharmacol Ther       Date:  2018-05-06       Impact factor: 12.310
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.